Patient-related outcomes with the use of checkpoint inhibitors for the treatment of metastatic non-small cell lung cancer

Transl Lung Cancer Res. 2018 Apr;7(Suppl 2):S138-S141. doi: 10.21037/tlcr.2018.03.09.

Authors

Jyoti Malhotra¹, Salma K Jabbour¹

Affiliation

¹ Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.

No abstract available

Publication types

Editorial
Comment